Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. SPY
7. TMUS
8. UNP
9. GOOGL
10. RNG

Go back to Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
(NASDAQ: PSTV) Delayed: 3.83 +0.05 (1.32%)
Previous Close $3.78    52 Week High $ 
Open $3.81    52 Week Low $ 
Day High $4.00    P/E N/A 
Day Low $3.81    EPS $ 
Volume 64,130